Positive preliminary recommendation for reimbursement of Ciltacel for MM in Canada. An important step in the right direction to help our MM patients access this important therapy. We will be ready @HamHealthSci @MyelomaCanada @ResearchMyeloma
.@pmcancercentre has launched an innovative and promising at-home-care program for hematologic cancer patients receiving an allogeneic stem cell transplant— a model of care which has been clinically proven to improve survival rates.